Zezhong Liu

Title: Zezhong Liu: Innovator in Antiviral Research

Introduction

Zezhong Liu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of antiviral research, particularly through his innovative patents. With a total of 2 patents, Liu's work focuses on developing novel strategies to combat viral infections.

Latest Patents

Liu's latest patents include a fusion protein and its applications. This fusion protein comprises a trimerization block and an immunogenic block connected by a linker. The trimerization block consists of repeat units, while the immunogenic block is derived from a pathogen, such as a coronavirus RBD block, HIV membrane protein, or influenza virus hemagglutinin protein. This innovative approach allows for a higher neutralizing antibody level compared to an immunogen monomer, promoting a more focused immune response.

Another significant patent is for a broad-spectrum polypeptide against enteroviruses. This invention provides a series of polypeptides with antiviral activity, offering a new strategy for preventing and controlling enteroviruses like EV71, CVA16, CVA6, CVB3, and CVB5. Liu's work lays a theoretical foundation for the development of small molecule drugs targeting these viruses.

Career Highlights

Liu has worked with notable institutions, including Fudan University and Shanxi Jinbo Bio-pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in the field of biotechnology and antiviral research.

Collaborations

Some of Liu's notable coworkers include Shibo Jiang and Lu Lu. Their collaborative efforts have further advanced the research and development of innovative antiviral solutions.

Conclusion

Zezhong Liu is a key figure in the field of antiviral research, with a focus on developing effective strategies against viral infections. His innovative patents and collaborations highlight his commitment to advancing medical science and improving public health.